Lattice Biologics Ltd. (TSXV:LBL) announced a private placement of 5,239,900 units at a price of CAD 0.20 per unit for gross proceeds of $800,000 (CAD 1,047,980) on January 19, 2017. Each unit consists of one common share and one half of one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire additional common share at CAD 0.265 per share for a period of 36 months from the date of closing. The transaction is subject to TSX Venture Exchange approval. The currency conversion was done through www.oanda.com as of January 19, 2017.